Tartrate-resistant acid phosphatase 5b: A novel serum marker of bone resorption

Journal of Bone and Mineral Research

Volumn 15, Issue 7, 2000, Pages 1337-1345

  Halleen, Jussi M ^a   Alatalo, Sari L ^a   Suominen, Harri ^b   Cheng, Sulin ^b   Janckila, Anthony J ^c   Väänänen, H Kalervo ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antiresorptive treatment; Immunoassay; Osteoclast; Sialic acid; Tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE; HORMONE; MONOCLONAL ANTIBODY; PLACEBO; SIALIC ACID; TARTARIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PURIFICATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MENOPAUSE; OSTEOCLAST; OSTEOLYSIS; PH; POSTMENOPAUSE;

EID: 0034047217     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.7.1337     Document Type: Article

References (35)

1. Garnero P, Delmas PD 1996 Measurement of biochemical markers: Methods and limitations. In: Bilezikian JP, Raisz LG, Rodan GA, (eds). Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 1277-1291.
2. Seibel MJ, Pols HAP 1996 Clinical application of biochemical markers of bone metabolism. In: Bilezikian JP, Raisz LG, Rodan GA, (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A. pp. 1293-1311.
3. Karmatschek M, Maier I, Seibel MJ, Woitge HW, Ziegler R, Armbruster FP 1997 Improved purification of bone sialoprotein and development of a homologous radioimmunoassay. Clin Chem 43:2076-2082.
4. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L 1993 Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation. Clin Chem 39:635-640.
5. Bonde M, Garnero P, Fledelius C, Quist P, Delmas PD, Christiansen C 1997 Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen. J Bone Miner Res 12:1028-1034.
6. Clemens JD, Herrick MV, Singer FR, Eyre DR 1997 Evidence that serum NTx (collagen-type I N-telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 43: 2058-2063.
7. Yaziji H, Janckila AJ, Lear SC, Martin AW, Yam LT 1995 Immunohistochemical detection of tartrate-resistant acid phosphatase in nonhematopoietic human tissues. Am J Clin Pathol 104:397-402.
8. Li CY, Yam LT, Lam KW 1970 Acid phosphatase isoenzyme in human leukocytes in normal and pathological conditions. J Histochem Cytochem 18:473-481.
9. Lam KW, Eastlund DT, Li C-Y, Yam LT 1978 Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children. Clin Chem 24:1105-1108.
10. Lam KW, Li CY, Yam LT, Desnick RJ 1981 Comparison of the tartrate-resistant acid phosphatase in Gaucher's disease and leukemic reticuloendotheliosis. Clin Biochem 14:177-181.
11. Lam KW, Desnick RJ 1982 Biochemical properties of the tartrate-resistant acid phosphatase activity in Gaucher disease. Prog Clin Biol Res 95:267-278.
12. Lau KHW, Onishi T, Wergedal JE, Singer FR, Baylink DJ 1987 Characterization and assay of tartrate-resistant acid phosphatase activity in serum: Potential use to assess bone resorption. Clin Chem 33:458-462.
13. Scarnecchia L, Minisola S, Pacitti MT, Carnevale V, Romagnoli E, Rosso R, Mazzuoli GF 1991 Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 51: 517-524.
14. Alvarez L, Peris P, Bedini JL, Pares A. Monegal A, Guañabens N, Mas E, Aibar C. Ballesta AM 1999 High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: Relevance as a marker of bone resorption in jaundiced patients. Calcif Tissue Int 64:301-303.
15. Kraenzlin ME, Lau KHW, Liang L, Freeman TK, Singer FR, Stepan J. Baylink DJ 1990 Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase. J Clin Endocrinol Metab 71:442-451.
16. Cheung CK, Panesar NS, Haines C, Masarei J, Swaminathan R 1995 Immunoassay of a tartrate-resistant acid phosphatase in serum. Clin Chem 41:679-686.
17. Chamberlain P, Compston J, Cox TM, Hayman AR, Imrie RC, Reynolds K, Holmes SD 1995 Generation and characterization of monoclonal antibodies to human type-5 tartrate-resistant acid phosphatase: Development of a specific immunoassay of the isoenzyme in serum. Clin Chem 41:1495-1499.
18. Halleen J, Hentunen TA, Hellman J, Väänänen HK 1996 Human bone tartrate-resistant acid phosphatase: Purification and development of an immunoassay. J Bone Miner Res 11:1444-1452.
19. Halleen JM, Hentunen TA, Karp M, Käkönen S-M, Pettersson K, Väanänen HK 1998 Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay. J Bone Miner Res 13:683-687.
20. Cheng S, Suominen H, Ollikainen S, Goll J, Taaffe D, Fuerst T, Njeh CF, Genant HK 1999 Comparison of ultrasound and bone mineral density assessment of the calcaneus with different regions of interest in healthy early menopausal women. J Clin Densitom2:117-126.
21. Hannon R, Blumsohn A, Naylor K, Eastell R 1998 Response of biochemical markers of bone turnover to hormone replacement therapy: Impact of biological variability. J Bone Miner Res 13:1124-1133.
22. Halleen JM, Karp M, Viloma S, Laaksonen P, Hellman J, Käkönen SM, Stepan JJ, Holmes SD, Väanänen HK, Pettersson K 1999 Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies. J Bone Miner Res 14:464-469.
23. Salo J, Metsikkö K, Palokangas H, Lehenkari P, Väanänen HK 1996 Bone-resorbing osteoclasts reveal a dynamic division of basal membrane into two different domains. J Cell Sci 106: 301-307.
24. Nesbitt SA, Horton M 1997 Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 276:266-269.
25. Salo J, Lehenkari P, Mulari M, Metsikkö K, Väanänen HK 1997 Removal of osteoclast bone resorption products by transcytosis. Science 276:270-273.
26. Halleen JM, Räisänen S, Salo JJ, Hentunen TA, Reddy SV, Roodman DG, Lehenkari PP, Kaija H, Vihko P, Väanänen HK Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274:22907-22910.
27. Scheven BAA, Milne JS, Robins SP 1997 A novel culture system to generate osteoclasts and bone resorption using porcine bone marrow cells: Role of M-CSF. Biochem Biophys Res Commun 231:231-235.
28. Stepan JJ, Lau KHW, Mohan S, Kraenzlin M, Baylink DJ 1989 Purification and N-terminal amino acid sequence of two tartrate-resistant acid phosphatase type-5 from the hairy cell leukemia spleen. Biochem Biophys Res Commun 165:1027-1034.
29. Janckila AJ, Woodford TA, Lam KW, Li CY, Yam LT 1992 Protein-tyrosine phosphatase activity of hairy cell tartrate-resistant acid phosphatase. Leukemia 6:199-203.
30. Kaija H, Jia J, Lindqvist Y, Andersson G, Vihko P 1999 Tartrate-resistant bone acid phosphatase: Large-scale production and purification of the recombinant enzyme, characterization, and crystallization. J Bone Miner Res 14:424-430.
31. Halleen JM, Kaija H, Stepan JJ, Salo JJ, Vihko P, Väänänen HK 1998 Studies on the protein tyrosine phosphatase activity of tartrate-resistant acid phosphatase. Arch Biochem Biophys 352:97-102.
32. Frenkel EP 1993 Gaucher disease: A heterogeneous clinical complex for which effective enzyme replacement has come of age. Am J Med Sci 305:331-344.
33. Troy K, Cuttner J, Reilly M, Grabowski G, Desnick R 1985 Tartrate-resistant acid phosphatase staining of monocytes in Gaucher disease. Am J Hematol 19:237-244.
34. Rosenthal RL 1982Serum acid phosphatase in Gaucher disease before and after splenectomy. In: Desnick RJ, Gatt S, Grabowski GA (eds.) Gaucher Disease: A Century of Delineation and Research. Alan R Liss, New York, NY, U.S.A., p. 279.
35. Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ 1999 Novel serum markers of bone resorption: Clinical assessment and comparison with established urinary indices. J Bone Miner Res 14:792-801.